home / stock / jnce / jnce news

JNCE News and Press, Jounce Therapeutics Inc.

Stock Information
Company Name: Jounce Therapeutics Inc.
Stock Symbol: JNCE
Market: NASDAQ
Website: jouncetx.com
Menu
JNCE JNCE Quote JNCE Short JNCE News JNCE Articles JNCE Message Board
Get JNCE Alerts

News, Short Squeeze, Breakout and More Instantly...
JNCE - Jounce Therapeutics Announces Closing of Tender Offer

CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Co...
JNCE - Jounce Acquisition: Exploring Whether It Is Worth It To Pay Up For CVR Value

2023-04-18 16:26:35 ET Summary Jounce Therapeutics, Inc. is being acquired by Concentra, a subsidiary of Tang Capital Partners, at $1.85 per share in cash, plus a non-tradeable CVR. Concentra's offer was deemed better than a merger with Redx Pharma or liquidation overseen by curre...

JNCE - Termination of Proposed Business Combination of Jounce Therapeutics, Inc. and Redx Pharma plc

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. ("Jounce" or t...

JNCE - AAOI, CMPR and WISA among mid-day movers

2023-03-27 13:06:40 ET Gainers: WiSA Technologies ( WISA ) +93% . First Citizens BancShares ( FCNCA ) +50% . Alimera Sciences ( ALIM ) +38% . Cimpress ( CMPR ) +30% . Gorilla Technology Group ( GRRR ) +25% . CBL International...
JNCE - Jounce jumps 23% as Concentra agrees to acquire for $1.85 per share cash

2023-03-27 10:47:28 ET Immunotherapy biotech Jounce Therapeutics ( NASDAQ: JNCE ) added ~23% on Monday after announcing that Concentra Biosciences agreed to acquire it for $1.85 in cash per share plus a non-tradeable contingent value right (CVR). Upfront cash considera...

JNCE - NBRV, JNCE and ALIM among healthcare movers

2023-03-27 10:47:00 ET Gainers: Pyxis Oncology ( PYXS ) +25% . Delcath Systems DCTH +23% . Jounce Therapeutics ( JNCE ) +23% . Alimera Sciences ( ALIM ) +22% . Coeptis Therapeutics ( COEP ) +21% . Losers: Unity Biotechnology ...

JNCE - Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE)...
JNCE - Penny Stocks To Buy Now: 7 To Watch Before Next Week

2023-03-17 11:05:13 ET Shares in small companies priced below $5 are known as penny stocks . They’re typically characterized by their high volatility and limited liquidity. This makes them a risky investment choice, but they also provide unique advantages and prospects for trader...

JNCE - Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian Cancer

CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (Nasdaq: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that patients from the INNATE Phase 2 trial in the ovarian ca...

JNCE - 5 Top Penny Stocks To Buy In March According To Insiders

2023-03-16 12:43:49 ET Penny stocks have long been a popular option for retail traders looking to make a quick buck. These are low-priced shares that small or newly established companies often offer. While investing in penny stocks can be highly risky, there is always the potential for ...
Next 10